Lefèvre J P, Nowak P, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3715470 A1, 2017-09-27.
发明人胡光,杨光,周伟. "Method for the Synthesis of 6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine 1,1-dioxide" [P]. 中国发明专利, 专利号 CN 108161443 A, 授权公告日 2015-08-18.
发明人韩伟,黄志刚,张德明. "A Process for Preparing High-Purity 6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine 1,1-dioxide" [P]. 中国发明专利, 专利号 CN 115561433 B, 授权公告日 2025-01-01.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 757, 4545-4557.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2021, 1100, (7), 8989-8996.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno-[3,2-e][1,2]thiazine 1,1-dioxide Using HRMS and NMR". J. Sep. Sci., 2013, 2333, (9), 1927-1941.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2014, 2223, 2912-2921.